Natarajan Sethuraman
Chief Scientific Officer, Entrada Therapeutics, Inc.
Companies
- Entrada Therapeutics, Inc.President Oct 18, 2024 to now1
- Entrada Therapeutics, Inc.Chief Scientific Officer Oct 28, 2021 to Sep 10, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Entrada Therapeutics, Inc. TRDA214,238 shares3$1.0M at $4.81Sep 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 2, 2026Shares withheld for tax 2,079 shares at $7.14 of Entrada Therapeutics, Inc.3
- May 4, 2026Sold 25,907 shares at $15.39 of Entrada Therapeutics, Inc.4
- Mar 3, 2026Shares withheld for tax 7,577 shares at $11.76 of Entrada Therapeutics, Inc.5
- Mar 2, 2026Shares withheld for tax 3,898 shares at $11.66 of Entrada Therapeutics, Inc.5
- Mar 1, 2026Granted 55,800 shares of Entrada Therapeutics, Inc.5
- Sep 2, 2025Shares withheld for tax 1,760 shares at $5.43 of Entrada Therapeutics, Inc.6
- Mar 3, 2025Shares withheld for tax 6,138 shares at $11.68 of Entrada Therapeutics, Inc.7
- Mar 1, 2025Granted 60,800 shares of Entrada Therapeutics, Inc.7
- Dec 3, 2024Sold 11,703 shares at $20.15 of Entrada Therapeutics, Inc.8
- Dec 2, 2024Sold 4,088 shares at $20.26 of Entrada Therapeutics, Inc.8
- Nov 29, 2024Sold 100 shares at $20.00 of Entrada Therapeutics, Inc.8
- Nov 13, 2024Sold 2,700 shares at $20.04 of Entrada Therapeutics, Inc.9
- Nov 11, 2024Sold 1,409 shares at $20.01 of Entrada Therapeutics, Inc.9
- Nov 6, 2024Sold 2,745 shares at $19.32 of Entrada Therapeutics, Inc.10
- Nov 6, 2024Sold 9,554 shares at $18.71 of Entrada Therapeutics, Inc.10
- Nov 5, 2024Sold 5,171 shares at $18.18 of Entrada Therapeutics, Inc.10
- Nov 4, 2024Sold 749 shares at $18.02 of Entrada Therapeutics, Inc.10
- Oct 16, 2024Sold 600 shares at $18.00 of Entrada Therapeutics, Inc.11
- Sep 9, 2024Sold 2,642 shares at $15.09 of Entrada Therapeutics, Inc.12
- Sep 6, 2024Sold 600 shares at $15.24 of Entrada Therapeutics, Inc.12
- Sep 5, 2024Shares withheld for tax 167 shares at $15.13 of Entrada Therapeutics, Inc.13
- Sep 4, 2024Shares withheld for tax 955 shares at $15.42 of Entrada Therapeutics, Inc.13
- Sep 3, 2024Shares withheld for tax 14 shares at $17.70 of Entrada Therapeutics, Inc.13
- Sep 3, 2024Shares withheld for tax 151 shares at $16.93 of Entrada Therapeutics, Inc.13
- Sep 3, 2024Shares withheld for tax 469 shares at $15.76 of Entrada Therapeutics, Inc.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed May 4, 2026
- 5SEC EDGARForm 4 filed Mar 3, 2026
- 6SEC EDGARForm 4 filed Sep 4, 2025
- 7SEC EDGARForm 4 filed Mar 4, 2025
- 8SEC EDGARForm 4 filed Dec 3, 2024
- 9SEC EDGARForm 4 filed Nov 13, 2024
- 10SEC EDGARForm 4 filed Nov 6, 2024
- 11SEC EDGARForm 4 filed Oct 18, 2024
- 12SEC EDGARForm 4 filed Sep 10, 2024
- 13SEC EDGARForm 4 filed Sep 5, 2024